Clinical Trials Directory

Trials / Completed

CompletedNCT04597814

The Relationship Between the Tumor Markers and Interstitial Lung Disease

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients. This study was undertaken to investigate the source of these serum tumor markers.

Detailed description

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients. This study was undertaken to investigate the source of these serum tumor markers.We hypothesis that these tumor markers are released from the lung. The broncholveolr lvge fluid levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 were measured in the interstitial lung disease patients before lung transplantation. The immunohistochemical test was performed in the specimen lung after lung transplantation.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionNo Intervention

Timeline

Start date
2019-01-01
Primary completion
2020-10-15
Completion
2020-10-15
First posted
2020-10-22
Last updated
2020-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04597814. Inclusion in this directory is not an endorsement.